ENTITY

Arecor Therapeutics (AREC LN)

1
Analysis
Health Care • United Kingdom
Arecor Therapeutics PLC is a clinical-stage biopharmaceutical company focused on developing superior therapeutics to address unmet patient needs in diabetes, obesity, and other cardiometabolic diseases. The company utilizes its proprietary ArestatĀ® formulation technology platform to create enhanced reformulations of therapeutic products and to develop a portfolio of proprietary products, including AT278, an ultra-rapid acting insulin. Arecor Therapeutics plc was founded in 2007 and is headquartered in Little Chesterford, United Kingdom.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x